Most patients report minimal discomfort, often describing the sensation as a warm or cooling feeling
Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss
Piecuch M, Garbicz J, Waliczek M, Malinowska-Borowska J
doi: 10.1152/physrev.00015.2019 111 GrossP
It is the first and only Semaglutide tablet formulation, providing an effective and convenient alternative to injectable diabetes medications